TES Co., Ltd (KOSDAQ:095610)

G1 Therapeutics Revenue

TES Co., Ltd had revenue of 84.50B KRW in the quarter ending March 31, 2025, with 100.37% growth. This brings the company's revenue in the last twelve months to 282.40B, up 84.79% year-over-year. In the year 2024, TES Co., Ltd had annual revenue of 240.08B with 63.39% growth.

• Revenue (ttm): 282.40B
• Revenue Growth: +84.79%
• P/S Ratio: 1.72
• Revenue / Employee: 704.25M
• Employees: 401
• Market Cap: 486.77B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	240.08B	93.14B	63.39%
Dec 31, 2023	146.94B	-211.05B	-58.95%
Dec 31, 2022	357.99B	-17.20B	-4.59%
Dec 31, 2021	375.19B	129.23B	52.54%
Dec 31, 2020	245.97B	67.59B	37.89%